M. B. Jacobsen

1.1k total citations
18 papers, 829 citations indexed

About

M. B. Jacobsen is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, M. B. Jacobsen has authored 18 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Neurology. Recurrent topics in M. B. Jacobsen's work include Neuroendocrine Tumor Research Advances (9 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (3 papers). M. B. Jacobsen is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (3 papers). M. B. Jacobsen collaborates with scholars based in Norway, Sweden and United States. M. B. Jacobsen's co-authors include L. E. Hanssen, Hans Rahme, E. Schrumpf, O. Fausa, K. Elgjo, Barbro Eriksson, Elisabeth G.E. de Vries, René Fiasse, Pasi Salmela and Matti Välimäki and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Nutrition.

In The Last Decade

M. B. Jacobsen

18 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. B. Jacobsen Norway 11 407 278 276 192 166 18 829
Clorinda Ciafardini Italy 17 506 1.2× 288 1.0× 423 1.5× 66 0.3× 177 1.1× 27 779
M. Eric Gershwin United States 11 85 0.2× 71 0.3× 35 0.1× 125 0.7× 47 0.3× 15 459
Maida Wong United States 8 86 0.2× 31 0.1× 130 0.5× 408 2.1× 35 0.2× 12 741
Paul Bălănescu Romania 14 136 0.3× 35 0.1× 67 0.2× 196 1.0× 103 0.6× 54 524
Susumu Konda Japan 14 86 0.2× 24 0.1× 78 0.3× 232 1.2× 100 0.6× 41 611
Yoshioki Yamasaki Japan 16 543 1.3× 79 0.3× 16 0.1× 152 0.8× 36 0.2× 33 870
Catherine H. Orteu United Kingdom 17 155 0.4× 25 0.1× 77 0.3× 419 2.2× 89 0.5× 32 943
J. Simón Mexico 14 51 0.1× 25 0.1× 59 0.2× 248 1.3× 66 0.4× 23 667
Liana De Vecchis Italy 13 92 0.2× 100 0.4× 543 2.0× 232 1.2× 32 0.2× 32 842
Cristina Suárez Ferrer Spain 12 115 0.3× 16 0.1× 130 0.5× 59 0.3× 120 0.7× 54 585

Countries citing papers authored by M. B. Jacobsen

Since Specialization
Citations

This map shows the geographic impact of M. B. Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. B. Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. B. Jacobsen more than expected).

Fields of papers citing papers by M. B. Jacobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. B. Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. B. Jacobsen. The network helps show where M. B. Jacobsen may publish in the future.

Co-authorship network of co-authors of M. B. Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of M. B. Jacobsen. A scholar is included among the top collaborators of M. B. Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. B. Jacobsen. M. B. Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jacobsen, M. B., et al.. (2004). Testosterone Modulates K+ ATPChannels in Sertoli Cell Membrane via the PLC-PIP2Pathway. Hormone and Metabolic Research. 36(8). 519–525. 29 indexed citations
2.
Wymenga, A.N.M., Barbro Eriksson, Pasi Salmela, et al.. (1999). Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms. Journal of Clinical Oncology. 17(4). 1111–1111. 161 indexed citations
3.
Wymenga, A.N.M., Barbro Eriksson, Pasi Salmela, et al.. (1999). Efficacy and Safety of Prolonged-Release Lanreotide in Patients with Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms. University of Groningen research database (University of Groningen / Centre for Information Technology). 17(4). 1111–1117. 1 indexed citations
4.
Zhou, Ya‐Qun, A Gobl, M. B. Jacobsen, et al.. (1998). Expression of p68 protein kinase and its prognostic significance during IFN-α therapy in patients with carcinoid tumours. European Journal of Cancer. 34(13). 2046–2052. 21 indexed citations
5.
Reseland, Janne E., Halvor Holm, M. B. Jacobsen, Trond Jenssen, & L. E. Hanssen. (1996). Proteinase Inhibitors Induce Selective Stimulation of Human Trypsin and Chymotrypsin Secretion. Journal of Nutrition. 126(3). 634–642. 31 indexed citations
6.
Jacobsen, M. B. & Hans Rahme. (1996). A Prospective, Randomized Study with an Independent Observer Comparing Open Carpal Tunnel Release with Endoscopic Carpal Tunnel Release. Journal of Hand Surgery (European Volume). 21(2). 202–204. 84 indexed citations
7.
Jacobsen, M. B. & M H Vatn. (1996). [Sick of food? Knowledge and hypothesis on food intolerance].. PubMed. 111(4). 109–12, 118. 1 indexed citations
8.
Reseland, Janne E., H. Holm, Trond Jenssen, M. B. Jacobsen, & L. E. Hanssen. (1995). Inhibitor-Stimulated Non-Parallel Pancreatic Secretion in Man: Hormonal and Neural Regulation?. Scandinavian Journal of Gastroenterology. 30(1). 72–80. 10 indexed citations
9.
Jacobsen, M. B., et al.. (1995). Cardiac manifestations in mid-gut carcinoid disease. European Heart Journal. 16(2). 263–268. 30 indexed citations
10.
Jacobsen, M. B. & L. E. Hanssen. (1995). Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours Report on a double‐blind, randomized trial. Journal of Internal Medicine. 237(3). 269–275. 41 indexed citations
11.
Jacobsen, M. B., L. E. Hanssen, F. Kolmannskog, et al.. (1995). Interferon-α2b, with or without Prior Hepatic Artery Embolization: Clinical Response and Survival in Mid-Gut Carcinoid Patients: The Norwegian Carcinoid Study. Scandinavian Journal of Gastroenterology. 30(8). 789–796. 51 indexed citations
12.
Hammarström, Lennart, Rolf Gustafson, Thomas Nyström, et al.. (1995). Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. The Lancet. 345(8946). 365–369. 216 indexed citations
13.
14.
Jacobsen, M. B., et al.. (1993). Differential Diagnosis of Human Ascites: Inhibitors of the Contact System and Total Proteins. Scandinavian Journal of Gastroenterology. 28(9). 777–782. 6 indexed citations
15.
Jacobsen, M. B., et al.. (1992). The Effect of Somatostatin Analogue SMS 201—995 on Serotonin Levels in the Medium of Primary Carcinoid Cell Cultures. Scandinavian Journal of Gastroenterology. 27(12). 1077–1083. 5 indexed citations
16.
Hanssen, L. E., E. Schrumpf, M. B. Jacobsen, et al.. (1991). Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report. Acta Oncologica. 30(4). 523–527. 9 indexed citations
17.
Jacobsen, M. B., O. Fausa, K. Elgjo, & E. Schrumpf. (1990). Hepatic Lesions in Adult Coeliac Disease. Scandinavian Journal of Gastroenterology. 25(7). 656–662. 87 indexed citations
18.
Ke, Andersen, F Brandrup, & M. B. Jacobsen. (1979). [Calmuril-hydrocortisone and carbamide-hydrocortisone DAK. A comparison in the treatment of atopic dermatitis].. PubMed. 141(51). 3512–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clorinda Ciafardini Breakdown of academic impact, for papers by M. Eric Gershwin Breakdown of academic impact, for papers by Maida Wong Breakdown of academic impact, for papers by Paul Bălănescu Breakdown of academic impact, for papers by Susumu Konda Breakdown of academic impact, for papers by Yoshioki Yamasaki Breakdown of academic impact, for papers by Catherine H. Orteu Breakdown of academic impact, for papers by J. Simón Breakdown of academic impact, for papers by Liana De Vecchis Breakdown of academic impact, for papers by Cristina Suárez Ferrer
Rankless by CCL
2026